Theseus Pharmaceuticals Net Tangible Assets

Theseus Pharmaceuticals (THRX) currently reports a net tangible assets of $220M as of September 2023. That compares with $220M in the prior-year period — up 2.7% year over year. Use the charts on this page to explore Theseus Pharmaceuticals's net tangible assets history and peer comparisons.

Theseus Pharmaceuticals's net tangible assets increased from $220M to $220M — a 2.7% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Theseus Pharmaceuticals reported $220M in net tangible assets as of September 2023. That compares with $220M in the prior-year period — up 2.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $220M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Theseus Pharmaceuticals, and consider following THRX for alerts when major investors trade the stock.

Theseus Pharmaceuticals is classified in the Healthcare sector. On net tangible assets, it currently shows $220M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing THRX with unrelated industries.